Literature DB >> 33493949

Treatment-resistant depression and risk of all-cause mortality and suicidality in Danish patients with major depression.

Frederikke Hørdam Gronemann1, Martin Balslev Jørgensen2, Merete Nordentoft3, Per Kragh Andersen4, Merete Osler5.   

Abstract

OBJECTIVE: Treatment-resistant depression (TRD) has been associated with higher mortality and risk of suicide, but this has mainly been showed in few studies which did not include self-harm. The aim was to investigate the association of TRD with all-cause mortality, suicide and self-harm in a nationwide cohort of patients with major depression and explore any differences in relation to patient characteristics.
METHODS: First-time hospital contacts for major depression between January 1, 1996 and December 31, 2014 were identified in Danish patient registers (ICD-10: F32 and F33). TRD was defined as two shifts in antidepressant treatment, assessed from one year prior depression diagnosis until one year after. Information on mortality, suicide and self-harm was obtained from Danish registers and associations between TRD and the three prognostic outcomes were analyzed using Cox Proportional Hazard Regression.
RESULTS: TRD was not associated with all-cause mortality the first year of follow-up (adjusted HR (aHR) 1.04, 95% confidence interval (CI) [0.98-1.11]), and the HR for mortality was lower the following 1-5 years. However, TRD was associated with higher rates of suicide (0-1 year: aHR 2.20, 95% CI [1.77-2.74]; 1-5 years: aHR 1.70, 95% CI [1.42-2.03]) and self-harming behavior (0-1 year: aHR 1.51, 95% CI [1.36-1.66]; 1-5 years: aHR 1.59, 95% CI [1.48-1.70]). The above risk estimates varied only slightly across sociodemographic and clinical patient characteristics.
CONCLUSIONS: Patients with TRD have higher rates of suicide and self-harm compared with non-TRD patients, whereas there seems to be no increase overall in all-cause mortality - in fact, there was a lower rate at follow-up after 1 year. We found only a few differences in HRs for mortality or suicidality across patient characteristics.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Major depressive disorder; Mortality; Self-harm; Suicide; Treatment-resistant depression

Year:  2021        PMID: 33493949     DOI: 10.1016/j.jpsychires.2021.01.014

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  3 in total

1.  Mortality-causing mechanisms and healthcare resource utilisation of treatment-resistant depression: A six-year population-based cohort study.

Authors:  Vivien Ky Chan; Edmund Cl Cheung; Sandra Sm Chan; Martin Knapp; Joseph F Hayes; Min Fan; Francisco Tt Lai; Hao Luo; Terry Lum; Rosa Sm Wong; Lauren Kw Lau; Eric Yf Wan; Gloria Hy Wong; Esther Wy Chan; Patrick Ip; Ian Ck Wong; Xue Li
Journal:  Lancet Reg Health West Pac       Date:  2022-03-15

2.  Healthcare resource utilization in patients with treatment-resistant depression-A Danish national registry study.

Authors:  Kristoffer Jarlov Jensen; Frederikke Hørdam Gronemann; Mikkel Zöllner Ankarfeldt; Espen Jimenez-Solem; Sarah Alulis; Jesper Riise; Nikolaj Bødker; Merete Osler; Janne Petersen
Journal:  PLoS One       Date:  2022-09-27       Impact factor: 3.752

Review 3.  Esketamine and Psilocybin-The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review.

Authors:  Dominika Psiuk; Emilia Magdalena Nowak; Natalia Dycha; Urszula Łopuszańska; Jacek Kurzepa; Marzena Samardakiewicz
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.